c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion.
about
Cap-Independent Translational Control of CarcinogenesisMatrix Hyaluronan Promotes Specific MicroRNA Upregulation Leading to Drug Resistance and Tumor ProgressionPancreatic cancer stem cells: emerging target for designing novel therapyCCR5 receptor antagonists block metastasis to bone of v-Src oncogene-transformed metastatic prostate cancer cell lines.14-3-3σ Gene Loss Leads to Activation of the Epithelial to Mesenchymal Transition Due to the Stabilization of c-Jun ProteinE2F1-mediated FOS induction in arsenic trioxide-induced cellular transformation: effects of global H3K9 hypoacetylation and promoter-specific hyperacetylation in vitroSirt1-deficient mice have hypogonadotropic hypogonadism due to defective GnRH neuronal migration.Activator protein 1 (AP-1) contributes to EpCAM-dependent breast cancer invasion.Cancer stem cell heterogeneity: origin and new perspectives on CSC targetingOverexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer.Cervical cancer stem cells manifest radioresistance: Association with upregulated AP-1 activity.BEX2 has a functional interplay with c-Jun/JNK and p65/RelA in breast cancer.Beneficial bacteria stimulate host immune cells to counteract dietary and genetic predisposition to mammary cancer in mice.Impaired CK1 delta activity attenuates SV40-induced cellular transformation in vitro and mouse mammary carcinogenesis in vivoCell fate determination factor Dachshund reprograms breast cancer stem cell function.Eph receptor tyrosine kinases in cancer stem cellsCombined phosphoproteomics and bioinformatics strategy in deciphering drug resistant related pathways in triple negative breast cancer.SLIT/ROBO2 signaling promotes mammary stem cell senescence by inhibiting Wnt signaling.BCL-2 family protein, BAD is down-regulated in breast cancer and inhibits cell invasionThe role of breast cancer stem cells in metastasis and therapeutic implications.Mechanisms regulating the secretion of the promalignancy chemokine CCL5 by breast tumor cells: CCL5's 40s loop and intracellular glycosaminoglycansWD-repeat protein WDR13 is a novel transcriptional regulator of c-Jun and modulates intestinal homeostasis in mice.Nitric Oxide Regulates Gene Expression in Cancers by Controlling Histone Posttranslational Modifications.The milk protein α-casein functions as a tumor suppressor via activation of STAT1 signaling, effectively preventing breast cancer tumor growth and metastasis.Transcriptional profiling reveals elevated Sox2 in DNA polymerase ß null mouse embryonic fibroblasts.Didymin reverses phthalate ester-associated breast cancer aggravation in the breast cancer tumor microenvironmentTristetraprolin induces cell cycle arrest in breast tumor cells through targeting AP-1/c-Jun and NF-κB pathwayEYA1 phosphatase function is essential to drive breast cancer cell proliferation through cyclin D1.COP1 and GSK3β cooperate to promote c-Jun degradation and inhibit breast cancer cell tumorigenesis.Adipose microenvironment promotes triple negative breast cancer cell invasiveness and dissemination by producing CCL5.Identification of breast cancer patients based on human signaling network motifs.Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.Lysine demethylase KDM3A regulates breast cancer cell invasion and apoptosis by targeting histone and the non-histone protein p53.Cyclophosphamide alters the gene expression profile in patients treated with high doses prior to stem cell transplantation.Cell fate factor DACH1 represses YB-1-mediated oncogenic transcription and translationDirect regulation of FOXK1 by C-jun promotes proliferation, invasion and metastasis in gastric cancer cells.Proto-oncogenic miR-744 is upregulated by transcription factor c-Jun via a promoter activation mechanismHyaluronan-CD44 interaction promotes c-Jun signaling and miRNA21 expression leading to Bcl-2 expression and chemoresistance in breast cancer cells.Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating-cancer stem cells: distinct, overlapping or same populations.Breast cancer stem cells.
P2860
Q26744030-3B7104EE-40B1-4A1C-A3B3-97320DD694B2Q26748929-561ABA7A-5411-4A00-9A2E-8919DA0017DCQ26863365-3A0BB00E-3408-4079-BF89-91A038BDD23EQ27348129-FAA11A83-65F0-4CFA-928C-8092BE27E629Q28385396-A49A33AD-B645-4BC9-93CC-19E4300D9C78Q28393378-B7317DB1-F480-4C48-AD73-A30190F0ACE7Q30407885-F0AD6D9F-631E-42DC-9305-48EB9D85FB4CQ30427356-DA88D0C6-6842-41CF-85F7-0A3F786DB539Q33649230-8673F80C-6C38-4DF1-8E51-89242FE0CEE7Q33804529-393DE262-B1F6-437A-9BDF-CDFD9B725D42Q33881042-291EEFE6-48AD-4E45-8C6F-673DF2F31587Q33898297-969F1E07-F6B2-4BBC-AA4E-1E247B73897FQ34039445-C465BC96-DDBA-4086-BB43-CA7EAF0AB478Q34123850-A3AE5E98-02C1-47D3-829F-4B16A14243A6Q34503221-F499602F-102A-4903-BA81-C60923249125Q34527304-293D3A88-BC00-4CAB-874E-AB5546EA830AQ34588503-94FEC93F-2B21-4A40-9B86-DEE0CB6A1C71Q34699735-D41DA134-749C-4502-93F1-155630E61ED0Q35006788-40232337-501E-4B4F-9448-ACF67308F42BQ35070157-222B41B1-63E7-48E3-9C50-B557F19118E4Q35763876-686C1C12-6FE2-4E39-9A6C-E7B0BC5A99B8Q36286873-EB2BF4A4-0A0A-428D-83A7-90DB8664591DQ36378173-9BCDFA95-8B6E-477E-BEA0-83E2B7834DCEQ36426497-6080843A-99DD-4504-9A9C-CE7949D3E864Q36439915-DA4E4423-4D29-44A5-8FC1-109D995C3B8CQ36524400-64BCF333-0AAD-4FFD-B848-2E3FD520759DQ36561559-02F9CAC4-C409-4024-A519-A4DA6A559B46Q37128230-40A347C5-10CC-4E45-A723-DE9786F69A5EQ37162398-E67DD442-CC99-4A73-8DBF-8C73E6631016Q37269350-E1F51FFE-E7A5-48F2-B897-C897D1C25CA6Q37347804-9371A652-676F-4335-999F-FF0E62A1457CQ37374606-7B907706-2030-4B58-8EF6-ECCD24EE8109Q37478627-BD74A2C2-234C-43C2-AE7F-3DBC83FA9015Q37505854-E4958354-CCBD-4F79-A3EF-883B19611425Q37600210-2C165371-3E43-4AAE-9850-2332B3D21D81Q37603351-E1E55640-4815-4509-B409-A5ECCFDF759FQ37662172-8E000DDA-089E-474A-A886-91879234A5C3Q37683868-3627F165-0AFC-40D5-AE20-E127A5D61BEDQ37885165-AC978EB4-FACC-4A25-B0CA-DCACADE779CAQ37976224-76005690-9FB1-4137-B3DB-22CAE3E55D26
P2860
c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion
@nl
c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion.
@ast
c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion.
@en
type
label
c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion
@nl
c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion.
@ast
c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion.
@en
prefLabel
c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion
@nl
c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion.
@ast
c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion.
@en
P2093
P2860
P3181
P356
P1476
c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion.
@en
P2093
Manran Liu
Neal Flomenberg
Nicole E Willmarth
Richard G Pestell
Sanjay Katiyar
Xiaojing Ma
Xuanmao Jiao
P2860
P304
P3181
P356
10.1074/JBC.M110.100792
P407
P577
2010-01-06T00:00:00Z